Trials / Completed
CompletedNCT00538889
Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects
Combined Administration of Lecozotan SR and Citalopram: a Double Blind, Multiple Dose Study in Young Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety and tolerability of lecozotan SR and citalopram when coadministred to healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lecozotan SR | |
| DRUG | Citalopram |
Timeline
- Start date
- 2007-08-01
- Completion
- 2007-11-01
- First posted
- 2007-10-03
- Last updated
- 2007-12-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00538889. Inclusion in this directory is not an endorsement.